<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref061">
 <label>[61]</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Smith</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Wichmann</surname>
   <given-names>T</given-names>
  </string-name>, 
  <string-name>
   <surname>Factor</surname>
   <given-names>SA</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>DeLong</surname>
   <given-names>MR</given-names>
  </string-name> (
  <year>2012</year>) 
  <article-title>Parkinson’s disease therapeutics: New developments and challenges since the introduction of levodopa</article-title>. 
  <source>Neuropsychopharmacology</source>, 
  <volume>37</volume>, 
  <fpage>213</fpage>–
  <lpage>246</lpage>.
  <pub-id pub-id-type="pmid">21956442</pub-id>
 </mixed-citation>
</ref>
